1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > CNS Drug News 17 AUGUST 2015

CNS Drug News 17 AUGUST 2015

  • August 2015
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Amended Contrave Agreement Will Restore Working Relationship
Industry Trend Analysis - Glatopa And Biosimilars Will Be Increasingly Important For Sandoz
Industry Trend Analysis - Teva To Maintain Dominance In Global Generics
Industry Trend Analysis - Synthon's Glatiramer Promises Rich Rewards For Pfizer
Industry Brief - Enrolment Completed In Phase IIa Trial Of ATX-MS-1467 For Relapsing MS
Industry Brief - FDA Accepts Teva's NDA Filing For SD-809 In HD
Industry Brief - FDA Accepts Brintellix sNDA To Review Cognitive Effects In MDD
Industry Brief - FDA Reinstates Bioequivalence Requirements For Intellipharmaceutics' Dexmethylphenidate
Industry Brief - Aegis Granted Patents For Non-Invasive Delivery Of Triptan Antimigraine Drugs
Industry Brief - Mylan Launches Lidocaine Patch In US
Industry Brief - PAION Initiates EU Phase III Study Of Remimazolam In General Anaesthesia
Industry Trend Analysis - New Zubsolv Indication Will Improve Platform In A Static Market
Industry Brief - SAGE/FDA Reach SPA Agreement On SAGE-547 Phase III Trial In SRSE
Industry Brief - First Patient Treated In SAGE-547 Phase III Trial In SRSE
Industry Brief - Orexigen/Kwang Dong Sign South Korea Contrave Distribution Deal
Industry Brief - Boehringer Ingelheim And Circuit Therapeutics Enter Obesity Collaboration
Industry Brief - Neurocrine Completes Enrolment In NBI-98854 Phase III TD Study
Industry Brief - Pfizer's Recombinant IVIG Receives ODD For Rare Neurological Disorder
Industry Trend Analysis - Genomic Analysis Will Bring Success To CNS Pipelines
Industry Brief - Depomed Board Rejects Horizon's Revised Proposal
Industry Trend Analysis - Divesting Allergan's Generics Business Will Increase Pressure On CNS Franchise
Industry Brief - Ovid Therapeutics Completes Oversubscribed USD75mn Series B Financing
Industry Brief - CNS Conferences - November 2015

Table Of Contents

CNS Drug News 17 AUGUST 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Alcoholism and drug dependence and addiction, known as substance use disorders and rehabilitation treatments are classified as substance abuse treatment. Some of the common symptoms of drug abuse are ...

Psychotherapeutic Drugs Market: By Type (Antipsychotics, Antidepressants, Antimaniacs, and Anxiety Drugs) & By Geography -Forecast (2016-2021)

Psychotherapeutic Drugs Market: By Type (Antipsychotics, Antidepressants, Antimaniacs, and Anxiety Drugs) & By Geography -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • August 2016
  • by Industry ARC

Psychotherapeutic drugs are used to treat mental illnesses such as extreme mood swings, social withdrawal, long lasting depression, confused thinking, and suicidal thought. schizophrenia, bipolar disorder, ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.